We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Hofseth Biocare ASA (HBC) NOK1

Sell:2.01 NOK Buy:2.17 NOK Change: 0.02 NOK (0.95%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
Sell:2.01 NOK
Buy:2.17 NOK
Change: 0.02 NOK (0.95%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
Sell:2.01 NOK
Buy:2.17 NOK
Change: 0.02 NOK (0.95%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Contact details

Address:
Kipervikgata 13
ALESUND
6003
Norway
Telephone:
+47 (73) 102200
Website:
https://hofsethbiocare.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HBC
ISIN:
NO0010598683
Market cap:
821.77 million NOK
Shares in issue:
395.08 million
Sector:
Biotechnology
Exchange:
Oslo Stock Exchange
Country:
Norway
Currency:
Norwegian Krone
Indices:
Oslo All Share Index

Key personnel

  • Jon Odegard
    Chief Executive Officer
  • Karl Inge Slotsvik
    Chief Operating Officer
  • Bomi Framroze
    Chief Scientific Officer
  • Henriette Godo Heggdal
    QA/QC Manager, Director
  • James Berger
    Chief Commercial Officer
  • Roger Hofseth
    Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.